206 articles in this topic
Study reveals how specific antibodies affect tolerance to different rheumatoid arthritis medications, offering personalized treatment insights.
FIRST-RA study follows 300 patients to measure early pain relief and functional improvements with filgotinib treatment.
Advanced lung biopsy technique uncovers serious pneumonia complications from methotrexate treatment in rheumatoid arthritis patients.
Advanced genetic analysis reveals new pathways to personalized RA therapy, addressing treatment failures in 30-40% of patients.
Study of 61 RA patients reveals 85% satisfaction with knee replacement, with quality of life improvements predicting success better than clinical measures.
New research reveals JAK inhibitors significantly increase hearing loss when combined with aminoglycoside antibiotics.
New study reveals how 2023 drug safety warnings led to less effective treatment choices for rheumatoid arthritis patients.
Systematic review of 87 clinical trials reveals JAK inhibitors offer targeted therapy for rheumatoid arthritis with distinct safety profiles.
Researchers identify protein stress as key factor limiting natural killer cell survival in cancer treatment.
New research reveals how the immune system's own antibodies trigger diversification, creating broader protection against pathogens.
New research reveals the molecular pathway that makes sick animals avoid social contact to prevent disease spread.
New research reveals how our antibodies develop sophisticated defenses against harmful bacteria through repeated childhood infections.
